Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 4

3(37.5%)

Phase 3

1(12.5%)

8Total

N/A(4)

Phase 4(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03038360Completed

Prospective Study With AMI Patients Undergoing PCI

Role: collaborator

NCT04539145Phase 4Unknown

CHOCO-CABANA Trial

Role: collaborator

NCT02517827Not ApplicableUnknown

Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions

Role: lead

NCT01763476Not ApplicableCompleted

Atherectomy and Drug-Coated Balloon Angioplasty in Treatment of Long Infrapopliteal Lesions

Role: lead

NCT01398033Phase 3Withdrawn

Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis

Role: lead

NCT00664963Phase 4Completed

YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study

Role: lead

NCT01298947Not ApplicableUnknown

Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions

Role: lead

NCT00712309Not ApplicableUnknown

Endovascular Treatment of Popliteal Artery - Balloon Angioplasty Versus Primary Stenting

Role: lead

NCT00773539Phase 4Unknown

A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy

Role: lead

All 9 trials loaded